AIM
AZN icon

Alhambra Investment Management’s AstraZeneca AZN Stock Holding History

Alhambra Investment Management’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$539K Buy
2,840
+56
+2% +$10.5K 0.24% 92
2026
Q1 		$549K Sell
2,784
-27
-1% -$5.21K 0.25% 86
2025
Q4 		$517K Buy
2,811
+23
+0.8% +$4.03K 0.24% 90
2025
Q3 		$428K Buy
2,788
+498
+22% +$75.4K 0.2% 101
2025
Q2 		$320K Buy
+2,290
New +$321K 0.16% 133

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Alhambra Investment Management's AZN Position: Q2 2026 in Review

Alhambra Investment Management increased its AstraZeneca (AZN) stake by 2% in Q2 2026, buying an estimated $10.5K and bringing the position to 2,840 shares worth $539K. The position accounts for 0.24% of the portfolio, ranked #92.

Alhambra Investment Management first reported a position in AZN in Q2 2025 and has held it in 5 quarters since. The position peaked at $549K in Q1 2026. 537 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • Alhambra Investment Management held 2,840 shares of AstraZeneca worth $539K as of Q2 2026.
  • Alhambra Investment Management bought 56 AstraZeneca shares in Q2 2026, an estimated $10.5K.
  • AstraZeneca made up 0.24% of Alhambra Investment Management's portfolio in Q2 2026, its #92 holding.
  • Alhambra Investment Management first reported a position in AstraZeneca in Q2 2025 and has held it in 5 quarters since.
  • Alhambra Investment Management's AstraZeneca position peaked at $549K in Q1 2026.
  • 537 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Alhambra Investment Management's 13F filing for Q2 2026, filed 16 Jul 2026.